NCT07154823View on ClinicalTrials.gov

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2034

Study Completion Date

November 30, 2035

Conditions

Acute Myeloid Leukaemia (AML)

Interventions

OTHER

None - Observational Study

There are no interventions in this observational study.

All Listed Sponsors

lead

Tempus AI

INDUSTRY

NCT07154823 - A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies | Biotech Hunter | Biotech Hunter